Logo image
Sign in
Executive Summary: The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
Journal article   Peer reviewed

Executive Summary: The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

J. S. Bradley, C. L. Byington, S. S. Shah, B. Alverson, E. R. Carter, C. Harrison, S. L. Kaplan, S. E. MacE, G. H. McCracken, M. R. Moore, …
Clinical Infectious Diseases, Vol.53(7), pp.617-630
2011
PMID: 21890766

Abstract

amantadine amoxicillin ampicillin azithromycin beta lactam antibiotic cefalexin cefazolin cefdinir cefixime cefotaxime cefpodoxime cefprozil ceftibuten ceftriaxone cefuroxime clarithromycin clindamycin doxycycline erythromycin erythromycin lactobionate levofloxacin linezolid macrolide moxifloxacin oseltamivir oxacillin penicillin G rimantadine unindexed drug vancomycin zanamivir blood cell count blood culture childhood disease community acquired pneumonia emergency medicine hospitalization human infant disease laboratory diagnosis medical society nonhuman pediatric intensive care nursing practice guideline primary medical care priority journal pulse oximetry review thorax radiography video assisted thoracoscopic surgery virus virulence Child Child, Preschool Community-Acquired Infections Humans Infant Pneumonia Intensive Care

Details